Movie Industry

"The Man Who Lives with the King" Heads to TV Screens… SBS Chuseok Special Lineup

Director Jang Hang-jun’s “The Man Who Lives with the King” Starring Actors Park Ji-hoon and Yoo Hae-jin Seven months after its February release

Choi Hee-jae
2026-09-17 17:37:36
[Edaily Starin Choi Hee-jae Reporter] The movie "The Man Who Lives with the King" (Wangsa-nam), which drew 16.92 million viewers, is set to reach audiences this Chuseok.
Poster for the movie “The Man Who Lives with the King” (Photo courtesy of Showbox)

According to the SBS schedule released on the 17th, “The Man Who Lives with the King” will air on the 26th as a special Chuseok feature. It is scheduled to air at 9:30 p.m.
"The Man Who Lives with the King" is a historical drama set in Cheongnyeongpo in 1457, telling the story of Village Chief Eom Heung-do (played by Yoo Hae-jin), who voluntarily exiled himself to help revive the village, and the young former King Danjong Lee Hong-wi (played by Park Ji-hoon), who was deposed and exiled. Directed by Jang Hang-jun, the film garnered attention as the first Korean film to explore the untold story surrounding King Danjong.
According to the Korean Film Council’s integrated computer network on the 17th, “Wangsa-nam” has drawn a cumulative audience of 16.92 million. It is the only Korean film this year to have surpassed the 10-million-viewer mark. Seven months after its theatrical release last February, “Wangsa-nam” is now set to reach television audiences.

Economy

Corporation

IT·Science

Economy

"Aftermath of the Jensen Huang Scandal… U.S. to Impose Strict Export Controls on China"

“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
2026-11-13 17:31:12

Corporation

The BORN Korea Reports 3.7 Billion Won Operating Loss in Q3… Deficit Narrows

#The BORN Korea announced on the 13th that it posted a consolidated operating loss of 3.7 billion won in the third quarter of this year. This represents an improvement in the loss compared to the same…
2026-11-13 17:32:49

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02